In preclinical models, HIF2, the transcription factor formed by HIF2α and an ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) protein, and not the canonical HIF family member HIF1α, drives ccRCC proliferation ex vivo and in vivo5,6. This evidence concerns the gene ARNT and nonpapillary renal cell carcinoma.